Stem Cell Clinics Face Long Odds Against FDA in Legal Fight

Aug. 2, 2018, 6:51 PM UTC

Two stem cell clinic operators may be facing tough odds in a legal fight with the FDA to stay in business.

The Food and Drug Administration made a big splash in May when it took the stem cell clinic operators to court in California and Florida, seeking to shut them down for offering unapproved treatments the agency says are potentially dangerous. The FDA says the stem cell treatments produced by the clinics are drug products and therefore under the agency’s purview.

It’s part of a high-profile, ongoing effort the FDA announced last year to clamp down on what the agency ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.